Logo

American Heart Association

  17
  0


Final ID: MP2237

Association of Iron Deficiency with Pre-Heart Failure in the Hispanic/Latino Population: Results from the Echocardiographic Study of Latinos (ECHO-SOL)

Abstract Body (Do not enter title and authors here): Introduction
Iron deficiency is a well-established comorbidity for heart failure (HF), but its role in subclinical stages of HF remains unclear. This study aimed to examine the association between iron deficiency and pre-HF in a diverse Hispanic/Latino cohort in the United States.

Methods
Iron deficiency was assessed at baseline in the Hispanic Community Health Study (HCHS/SOL, 2008-2011) using a composite definition: ferritin <30 ng/dl and transferrin saturation <30% if the estimated glomerular filtration rate (eGFR) >60ml/min/1.73m2; or ferritin <300ng/dl and transferrin saturation <30% if eGFR <60ml/min/1.73m2, for both sexes. Echocardiographic outcomes were measured at two visits in the Echocardiographic Study of Latinos (ECHO-SOL) ancillary study (N=1643). Prevalent pre-HF at Visit 1 (2011–2014) was defined as ≥1 abnormal echocardiographic parameter: LVEF <50%, global longitudinal strain > -15%, diastolic dysfunction ≥ grade 1, left ventricular mass index >115 in men/>95 in women, relative wall thickness >0.42. Incident pre-HF was defined at Visit 2 (2015–2018) among participants without pre-HF at baseline (n=588). Multivariable logistic regression models adjusted for sociodemographic and clinical covariates. Stratified analyses of iron deficiency and prevalent pre-HF were conducted by CKD categories defined using eGFR (MDRD equation). All analyses accounted for complex survey design.

Results
Iron deficiency was present in n = 198 participants (mean age 56.1, female 82.1%). Participants with iron deficiency had higher proportions of prevalent pre-HF compared to those without (75.0% vs. 66.2%, p = 0.03) but no significant differences were seen among proportions of incident pre-HF (56.5% vs. 55.0%, p = 0.84). Iron deficiency increased the odds for prevalent pre-HF by 64% after full adjustments (OR 1.64, 95% CI 1.05–2.55, p = 0.03). In stratified models, iron deficiency was associated with almost a threefold increase in the odds of prevalent pre-HF among participants with mild CKD (OR 2.79, 95% CI 1.27–6.16) even after full adjustments, but not in those with normal or ≥ moderate CKD, Table 1. No significant association was found between iron deficiency and incident pre-HF (p = 0.84), Table 2.

Conclusions
Iron deficiency is independently associated with prevalent but not incident pre-HF in Hispanic/Latino adults, particularly in those with mild CKD. These findings highlight the importance of early iron status assessment in HF prevention strategies.
  • Agarwal, Rishab  ( Albert Einstein College of Medicine , Bronx , New York , United States )
  • Rodriguez, Carlos  ( Albert Einstein School of Medicine , Bronx , New York , United States )
  • Duran Luciano, Priscilla  ( Albert Einstein College of Medicine , Bronx , New York , United States )
  • Swett, Katrina  ( Albert Einstein College of Medicine , Bronx , New York , United States )
  • Lash, James  ( University of Illinois at Chicago , Chicago , Illinois , United States )
  • Isakova, Tamara  ( Northwestern University , Chicago , Illinois , United States )
  • Cai, Xuan  ( Northwestern University , Chicago , Illinois , United States )
  • Daviglus, Martha  ( UNIVERSITY ILLINOIS CHICAGO , Chicago , Illinois , United States )
  • Cai, Jianwen  ( UNC Chapel Hill , Chapel Hill , North Carolina , United States )
  • Mehta, Rupal  ( Northwestern University , Chicago , Illinois , United States )
  • Author Disclosures:
    Rishab Agarwal: DO NOT have relevant financial relationships | Carlos Rodriguez: DO have relevant financial relationships ; Researcher:Amgen, Inc.:Active (exists now) | Priscilla Duran Luciano: DO NOT have relevant financial relationships | Katrina Swett: No Answer | James Lash: DO NOT have relevant financial relationships | Tamara Isakova: DO NOT have relevant financial relationships | Xuan Cai: DO NOT have relevant financial relationships | Martha Daviglus: No Answer | Jianwen Cai: No Answer | Rupal Mehta: DO have relevant financial relationships ; Consultant:Novo Nordisk:Active (exists now) ; Individual Stocks/Stock Options:Abbvie:Active (exists now) ; Speaker:Boehringer Ingelheim:Active (exists now) ; Speaker:AstraZeneca:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Heart Failure in CKM Syndrome: Prevention, Management and Outcomes

Monday, 11/10/2025 , 01:45PM - 02:55PM

Moderated Digital Poster Session

More abstracts on this topic:
A Bridge from Sweet to Sour: A Case of Recurrent Myocardial Stunning in Diabetic Ketoacidosis

Satish Vikyath, Pargaonkar Sumant, Slipczuk Leandro, Schenone Aldo, Maliha Maisha, Chi Kuan Yu, Sunil Kumar Sriram, Borkowski Pawel, Vyas Rhea, Rodriguez Szaszdi David Jose Javier, Kharawala Amrin, Seo Jiyoung

A Case Presentation of Severe Left Ventricular Dysfunction from Focal Myocarditis due to Immune Checkpoint Inhibitor

Patel Romil, Hussain Kifah, Gordon Robert

More abstracts from these authors:
Preclinical Heart Failure Risk of Metabolically Healthy Overweight/Obese Adults in Hispanic/Latino Adults.

Krueger Mason, April-sanders Ayana, Talavera Gregory, Hurwitz Barry, Llabre Maria, Schneiderman Neil, Kaplan Robert, Rodriguez Carlos, Daviglus Martha, Cai Jianwen, Cheng Susan, Kansal Mayank

Association of Life’s Essential 8 Cardiovascular Health Scores with Pre-Heart Failure in a Hispanic/Latino Population-Based Cohort: Results from the Echocardiographic Study of Latinos (ECHO SOL)

Duran Luciano Priscilla, Allison Matthew, Isasi Carmen, Makarem Nour, Rodriguez Carlos, Alexander Melvin, Swett Katrina, Perreira Krista, Cheng Susan, Chandra Alvin, Sotres-alvarez Daniela, Elfassy Tali, Martinez Claudia

You have to be authorized to contact abstract author. Please, Login
Not Available